Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia Interventions: Drug: Teriflunomide; Drug: Dexamethasone Sponsors: Peking University People ' s Hospital; Beijing Luhe Hospital; Chinese PLA General Hospital; Navy General Hospital, Beijing; Beijing Hospital; Beijing Friendship Hospital; Peking University First Hospital; Peking University Third Hospital; China-Japan Friendship Hospital; Beijing Tsinghua Changgeng Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone
Conditions: Liver Cancer Interventions: Drug: Liposomal bupivacaine; Drug: Bupivacaine Hydrochloride combined with dexamethasone Sponsors: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)
Conditions: Diabetic Macular Edema Interventions: Drug: Dexamethasone ophthalmic suspension (OCS-01); Drug: Vehicle Sponsors: Oculis; ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Drug: Bortezomib; Procedure: Computed Tomography; Biological: Daratumumab; Drug: Daratumumab and Hyaluronidase-fihj; Drug: Dexamethasone; Drug: Lenalidomide; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Drug: Selinexor Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Magnesium Sulphate Versus Dexamethasone as an Adjuvant to Bupivacaine in TAP Block for Abdominal Hysterectomy
Conditions: TAP Block Interventions: Drug: transversus abdominis plane (TAP) block in Abdominal hysterectomy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Alnuctamab; Drug: Mezigdomide; Drug: Dexamethasone Sponsors: Celgene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety of Empliciti ® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
Conditions: Relapsed or Refractory Multiple Myeloma Interventions: Drug: Elotuzumab in combination with pomalidomide and dexamethasone; Drug: Elotuzumab in combination with lenalidomide and dexamethasone Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Comparative Assessment of Preoperative Versus Postoperative Submucosal Dexamethasone on Postoperative Complications Following Surgical Extraction of Mandibular Third Molar: Randomized Controlled Trial
Conditions: Pain, Postoperative Interventions: Drug: Dexamethasone Sponsors: B.P. Koirala Institute of Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
Conditions: Hemophagocytic Lymphohistiocytoses Interventions: Drug: Ruxolitinib; Drug: Etoposide; Drug: Dexamethasone; Procedure: Non-interventional Imaging; Procedure: Research Biopsy; Procedure: Biospecimen Collection Sponsors: University of California, San Francisco; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
A Study to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma Intravenously (IV) Infused ABBV-383 or Receiving Standard Available Therapies
Conditions: Multiple Myeloma Interventions: Drug: ABBV-383; Drug: Carfilzomib; Drug: Pomalidomide; Drug: Elotuzumab; Drug: Selinexor; Drug: Bortezomib; Drug: Dexamethasone Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Conditions: Multiple Myeloma Interventions: Drug: Elranatamab; Drug: Elotuzumab; Drug: Pomalidomide; Drug: Dexamethasone; Drug: Bortezomib; Drug: Carfilzomib Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Conditions: Multiple Myeloma Interventions: Drug: Elranatamab; Drug: Elotuzumab; Drug: Pomalidomide; Drug: Dexamethasone; Drug: Bortezomib; Drug: Carfilzomib Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Preoperative dexamethasone administration in hepatectomy of 25-min intermittent Pringle ’s maneuver for hepatocellular carcinoma: protocol for a randomized controlled trial
DiscussionBased on our previous study, we will explore further the effect of glucocorticoid administration on attenuating the surgical stress response in order to follow securely 25-min hepatic inflow occlusion. Therefore, the trial protocol is reasonable and the results of the trial may be clinically significant.Trial registrationThis trial was registered on 3 December 2022, in the Chinese Clinical Trial Registry (http://www.chictr.org.cn), ChiCTR2200066381. The protocol version is V1.0 (20221104). (Source: Trials)
Source: Trials - November 30, 2023 Category: Research Source Type: clinical trials
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Conditions: Multiple Myeloma; Renal Failure Interventions: Combination Product: Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone Sponsors: Augusta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Ultra High-risk Multiple Myeloma
Conditions: Multiple Myeloma; Primary Plasma Cell Leukemia; Extramedullary Multiple Myeloma Interventions: Drug: Daratumumab; Drug: Carfilzomib; Drug: Lenalidomide; Drug: Dexamethasone; Drug: Cisplatin; Drug: epirubicin; Drug: Cyclophosphamide; Drug: Etoposide; Drug: Melphalan; Procedure: ASCT; Drug: bortezomib Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
